Therapeutics News and Research

RSS

New discovery may lead to more effective treatments for osteoarthritis, other cartilage diseases

New information from a study reported on in STEM CELLS might result in more effective treatments for osteoarthritis and other cartilage diseases, as well as hereditary disorders affecting cartilage development.

25 Aug 2021

Study finds a new line of drugs to stimulate myelin repair in multiple sclerosis

In the nearly 1 million Americans living with multiple sclerosis, the fatty substance that insulates the nerves of the central nervous system—called myelin—is damaged.

24 Aug 2021

Study suggests a balanced approach to developing safer opioid analgesics

Opioids are powerful painkillers but their use is hindered because patients become tolerant to them, requiring higher and higher doses, and overdoses can cause respiratory depression and death.

24 Aug 2021

Glycyrrhizic acid as a drug candidate for COVID-19

A new study presents the benefits of licorice, an age-old herbal remedy, to treat COVID-19 at all stages.

24 Aug 2021

Online, video-based exercise program can help postpartum women with diastasis rectus abdominis

A study at Hospital for Special Surgery (HSS) finds that an online, video-based core exercise program can help with a condition many women experience after childbirth.

24 Aug 2021

Peptoids could one day cure or prevent herpes, COVID-19

In addition to antibodies and white blood cells, the immune system deploys peptides to fight viruses and other pathogens.

24 Aug 2021

Mission and money clash in nonprofit hospitals’ venture capital ambitions

Cone Health, a small not-for-profit health care network in North Carolina, spent several years developing a smartphone-based system called Wellsmith to help people manage their diabetes.

24 Aug 2021

First-in-kind kidney cancer drug developed at UTSW receives FDA approval

A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted at UT Southwestern Medical Center received approval from the Food and Drug Administration, providing a new treatment for patients with familial kidney cancer.

24 Aug 2021

Scientists develop a scalable method to harvest exosomes from unpasteurized cow's milk

Exosomes are nano-sized biological capsules that cells produce to protect and courier delicate molecules throughout the body.

23 Aug 2021

Aerosol from vaping devices likely impairs blood vessel function, rat study shows

Aerosol generated from vaping devices likely impairs blood vessels' ability to function comparable to traditional cigarette smoke, according to preliminary research in rats presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.

23 Aug 2021

FDA-approved antiplatelet drug shows potential as new, low-cost heart failure therapy

Sarpogrelate, an antiplatelet medication, has potential as a new heart failure therapy and, according to researchers, could potentially decrease health care costs associated with cardiovascular disease, according to preliminary animal research presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2021.

23 Aug 2021

FDA approves COVID-19 mRNA vaccine that uses fundamental Penn technology

The U.S. Food and Drug Administration has given the first full approval to a COVID-19 mRNA vaccine, which uses modified mRNA technology invented and developed by scientists in the Perelman School of Medicine at the University of Pennsylvania, whose years of research in mRNA science laid a critical piece of the foundation for the largest global vaccination campaign in history.

23 Aug 2021

New study reveals unique immune responses to SARS-CoV-2, Ebola and respiratory syncytial virus using B cell repertoire analysis

A new study has been published on the bioRxiv* preprint server, which takes a long-read repertoire amplification approach to better understand, compare and contrast B cell responses to emerging or endemic viruses.

23 Aug 2021

Curia to expand U.S. commercial manufacturing capability

Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced plans to expand its commercial manufacturing capacity at its Rensselaer, New York facility.

From Curia 23 Aug 2021

Study offers hope for an era of safer chemotherapy in breast cancer

Breast cancer is the deadliest and most common type of cancer in women. The treatment options often require administration of anti-cancer drugs in high doses, as the cells develop resistance towards chemotherapy, leading to painful side effects in patients.

23 Aug 2021

Nanotechnology provides novel solutions against zoonotic viruses

Therefore, scientists functionalize nanoparticles to act against these pathogenic viruses in a clinical strategy. In a recent review published in the journal Microbial Pathogenesis, researchers look at the novel solutions against zoonotic viruses provided by nanotechnology.

23 Aug 2021

DeepSARS simultaneously detects and conducts genomic surveillance of SARS-CoV-2

A new study discusses the development of DeepSARS, a high-throughput platform for diagnostic detection and genomic surveillance of SARS-CoV-2.

23 Aug 2021

Study examines COVID vaccination in California state prisons

In a new retrospective cohort study, researchers determined the efficacy of mRNA vaccines against COVID-19 among incarcerated people in California.

22 Aug 2021

Leducq Foundation awards $7 million for vascular malformation research

Luisa Iruela-Arispe, PhD, the Stephen Walter Ranson Professor of Cell Biology and chair of Cell and Developmental Biology, is the North American coordinator for an international collaboration that has received a five-year, $7 million Transatlantic Networks of Excellence Program award from the Leducq Foundation.

20 Aug 2021

New antibody found to be highly protective against wide range of COVID-19 virus variants

The virus that causes COVID-19 today is not the same as the one that first sickened people way back in December 2019.

20 Aug 2021

Therapeutics News and Research

New discovery may lead to more effective treatments for osteoarthritis, other cartilage diseases

Study finds a new line of drugs to stimulate myelin repair in multiple sclerosis

Study suggests a balanced approach to developing safer opioid analgesics

Glycyrrhizic acid as a drug candidate for COVID-19

Online, video-based exercise program can help postpartum women with diastasis rectus abdominis

Peptoids could one day cure or prevent herpes, COVID-19

Mission and money clash in nonprofit hospitals’ venture capital ambitions

First-in-kind kidney cancer drug developed at UTSW receives FDA approval

Scientists develop a scalable method to harvest exosomes from unpasteurized cow's milk

Aerosol from vaping devices likely impairs blood vessel function, rat study shows

FDA-approved antiplatelet drug shows potential as new, low-cost heart failure therapy

FDA approves COVID-19 mRNA vaccine that uses fundamental Penn technology

New study reveals unique immune responses to SARS-CoV-2, Ebola and respiratory syncytial virus using B cell repertoire analysis

Curia to expand U.S. commercial manufacturing capability

Study offers hope for an era of safer chemotherapy in breast cancer

Nanotechnology provides novel solutions against zoonotic viruses

DeepSARS simultaneously detects and conducts genomic surveillance of SARS-CoV-2

Study examines COVID vaccination in California state prisons

Leducq Foundation awards $7 million for vascular malformation research

New antibody found to be highly protective against wide range of COVID-19 virus variants

Event guide: The Non-Opioid Pain Therapeutics Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News